Key result
Progressive carotid stenosis detected by ultrasound increased the risk of major adverse cardiovascular events compared to nonprogressive disease.
Why the study?
Does progressive carotid stenosis detected by duplex ultrasonography predict major adverse cardiovascular events in cardiovascular high-risk patients?
Cohort (n=1,065)
Does progressive carotid stenosis detected by duplex ultrasonography predict major adverse cardiovascular events in cardiovascular high-risk patients?
Progression of carotid stenosis over 6-9 months detected by ultrasound is a strong predictor of midterm adverse cardiovascular events in high-risk patients.
Answers are grounded in this paper and cite their sources.
May enhance risk stratification in high-risk patients; hypothesis-generating pending prospective trials.
BACKGROUND AND PURPOSE: The progression of carotid stenosis reflects the activity of atherosclerotic disease and may indicate a risk for systemic atherothrombotic complications. We investigated whether progressive carotid stenosis determined by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. METHODS: We prospectively studied 1065 of 1268 consecutive patients initially asymptomatic with respect to carotid disease. Carotid ultrasound investigations at baseline and after a median of 7.5 months (range, 6 to 9 months) were performed to identify patients with progressive stenosis as defined by Doppler velocity criteria. Patients were then followed up clinically for a median of 3.2 years for the occurrence of major adverse cardiovascular events (composite MACEs: myocardial infarction, percutaneous coronary or peripheral interventions, coronary or vascular surgery, amputation, stroke, and all-cause mortality). RESULTS: We found progressive carotid stenosis in 93 patients (9%) by ultrasound and thereafter recorded 495 MACEs in 421 patients (40%) during clinical follow-up. Patients with progressive carotid stenosis had a significantly increased risk for cardiovascular events compared with patients with nonprogressive disease: adjusted hazard ratios and confidence intervals were 2.01 for composite MACEs (95% CI, 1.48 to 2.67, P<0.001), 2.38 for myocardial infarction (95% CI, 1.07 to 5.35, P=0.044), 1.59 for any coronary event (95% CI, 1.10 to 2.28, P=0.011), 2.00 for stroke (95% CI, 1.02 to 4.11, P=0.035), 2.42 for any peripheral vascular event (95% CI, 1.61 to 3.62, P<0.001), and 1.75 for cardiovascular death (95% CI, 1.03 to 2.97, P=0.039). CONCLUSIONS: Progression of carotid stenosis within a 6- to 9-month interval detected by duplex ultrasound predicts midterm clinical adverse events of atherosclerosis in high-risk patients affecting the coronary, cerebrovascular, and peripheral circulations.
No takes yet. Share an insight, caveat, or question.
Sabeti et al. (2007) conducted a cohort in Cardiovascular high-risk patients asymptomatic for carotid disease (n=1,065). Progressive carotid stenosis vs. Nonprogressive carotid disease was evaluated on Major adverse cardiovascular events (composite MACEs: myocardial infarction, percutaneous coronary or peripheral interventions, coronary or vascular surgery, amputation, stroke, and all-cause mortality) (HR 2.01, 95% CI 1.48 to 2.67, p=<0.001). Progressive carotid stenosis detected by ultrasound increased the risk of major adverse cardiovascular events compared to nonprogressive disease.
Synapse has enriched 10 related papers. Consider them for comparative context: